Results from a 24-week Phase III study showed that saxagliptin, a selective, reversible inhibitor of the dipeptidyl peptidase (DPP-4) enzyme in development by Bristol-Myers Squibb Company and AstraZeneca produced significant reductions in key measures of glucose control, A1C, FPG and PPG in treatment naïve people with type 2 diabetes compared …

We often have heard that Levemir has to be high dose to have the same 24 hour effect as Lantus. Now a new head to head study dispels that rumor. It appears that Detimir can be used once-daily and have a comparable blood glucose response to insulin glargine over a 24-hour period …

The ties being found between type 2 diabetes and obstructive sleep apnea (OSA) indicate these disorders have major implications on public health.

Amylin, Eli Lilly and Alkermes announced results from the DURATION-1 trial, a 30-week study that compared the efficacy of exenatide once weekly, a long-acting release formulation of exenatide, to BYETTA(R) (exenatide) injection.

Submitted to FDA for Stand-Alone Therapy in Q1 2008, studies show that exenatide can lower A1c 0.7 to 0.9 points as a mono therapy

Novo Nordisk announced headline clinical results from a phase 3 clinical study comparing the effects of liraglutide, a once-daily human GLP-1 analogue, with exenatide, a twice-daily GLP-1 analogue.

Bile acid aberration found in Type 2 diabetes patients and cholic acid has a significantly higher rate.

Francesco Rubino M.D.Chief, Section of Gastrointestinal Metabolic Surgery, Weill Cornell Medical College of Cornell University-New York is part of the 1st World Congress on Interventional Therapies for Type 2 Diabetes. He has done considerable work in researching surgery for diabetes control and has agreed to share his insights with you, …

It may be time to use the A1c to help diagnosis those 6.2 million people that have diabetes and are not aware.

For people with diabetes, high blood pressure poses a special threat, multiplying their risk of heart attacks, strokes and kidney problems. But a new study finds that even when people with diabetes show up in their doctor’s office with a high blood pressure reading, there’s only a 50-50 chance that …